About ALLOZYNE INC

Allozyne was a clinical stage biotechnology company headquartered in Seattle's biotech and high tech innovation corridor. Allozyne was founded in 2005 by California Institute of Technology researchers, and was incubated by Accelerator Corporation. Its lead product candidate, AZ01, is a long acting interferon beta for the treatment of the relapsing remitting form of multiple sclerosis, a chronic degenerative disease characterized by demyelination of nerve fibers leading to severe nerve damage and increasing disability. Multiple sclerosis is estimated to affect 400,000 individuals in the US alone and 2.5 million worldwide. AZ01 is currently undergoing Phase I clinical trials in the US. Preclinical data indicates that AZ01 has the potential to be dosed once monthly compared to the current standard of care dosed anywhere from once daily to once per week. Source: Wikipedia
IndustryBiotechnology
HeadquartersSeattle, WA
Founded2005
Legal formC Corporation
StatusActive

Reviews

No reviews yet. Worked with ALLOZYNE INC? Be the first to share your experience.

Write a review →

Key figures

Sign in to see the key figures

Revenue, net income and head count of ALLOZYNE INC over the years, with their sources.

Sign in Create an account with your email

It's free

Location

Seattle, WA

Is this your company?

Claim this page for free to add your logo, products, photos and jobs, and to answer reviews.

Claim this page

Share this company

ALLOZYNE INCBiotechnologyhttps://heelky.com/explore/companies/allozyne-inc-64owvf45/

Copy link

Share on

QR code

Scan it with a phone camera to open this page, or download it for a flyer, a slide or a badge.

Join Heelky to connect, hire and grow

Create a free account to message people, apply to jobs and post missions.

Join now — it's free

Choose your language

Heelky will remember your choice.

Other languages

Available languages: 70 About languages on Heelky